Inhibrx Biosciences, Inc. (INBX) vs Oric Pharmaceuticals, Inc. (ORIC)
- Inhibrx Biosciences, Inc. INBX 89.83 −0.74%
- Oric Pharmaceuticals, Inc. ORIC 12.35 −3.29%
Inhibrx Biosciences, Inc. and Oric Pharmaceuticals, Inc. are both Biotechnology companies. Inhibrx Biosciences, Inc. and Oric Pharmaceuticals, Inc. are of similar size ($1.3B and $1.3B). Across the 10 metrics below, Inhibrx Biosciences, Inc. leads on 5 and Oric Pharmaceuticals, Inc. on 5.
Valuation
Profitability
| Metric | INBX | ORIC | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (1,773.60%) | (39.80%) | (56.36%) |
| Return on assets | (75.44%) | (37.35%) | (48.04%) |
| Return on invested capital | 0.00% | (83.77%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack